Document is current

Article History

Received: 5 October 2022

Accepted: 6 October 2022

First Online: 27 October 2022

Declarations

:

: Not applicable.

: Not applicable.

: Dennis Lee Sacdalan has received medical consulting fees for Unilab Inc; payment for lectures from AstraZeneca, Merck Sharp & Dohme, and Eli Lilly; payment for writing an unrelated manuscript from Pfizer; an education grant from Merck Sharp & Dohme, payment from Pfizer and Roche for participation on an advisory board.

: Gwo Fung Ho has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events for Boehringer Ingelheim, Pfizer, and AstraZeneca; support for attending meetings and/or travel from AstraZeneca and Bristol Myers Squibb; and has had a leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid, for Boehringer Ingelheim, Pfizer, AstraZeneca, Eli Lily, and Merck Sharp & Dohme. Gwo Fung Ho’s affiliated institution has received grants or contracts from AstraZeneca, Regeneron, Astellas, Merck Sharp & Dohme, Pfizer, Arcus Biosciences, Roche, and Adipolab.

: Rajiv Parakh has received honoraria for presentations and speaker bureau for Bayer, Boehringer Ingelheim, and Pfizer; and been a member on advisory boards for novel oral anticoagulants for Daitchi Sankyo, Bayer, Boehringer Ingelheim, and Pfizer.

: Nannette Rey has received honoraria for speakers bureaus for Boehringer Ingelheim, Servier, and Sanofi; has participated on an advisory board for Boehringer; and was the President of the Philippine Heart Association 2018–2019.

: Alexander Cohen has received contracts and consulting fees for other projects from Bristol Myers Squibb and Pfizer; payments for lectures and presentations from Bristol Myers Squibb and Pfizer; and Advisory Board fees for other projects from Bristol Myers Squibb and Pfizer, all paid to a consulting company.

: Lai Heng Lee, Pongwut Danchaivijitr, Noppacharn Uaprasert, Harinder Gill, Paresh Pai, and Jen-Kuang Lee have nothing to declare.